Skip to main content
. Author manuscript; available in PMC: 2021 Apr 28.
Published in final edited form as: ACS Nano. 2020 Apr 6;14(4):4255–4264. doi: 10.1021/acsnano.9b09618

Figure 6:

Figure 6:

Therapeutic efficacy of 89Zr-TiO2-Tf: Therapeutic study of 89Zr-TiO2-Tf (1.11 MBq/60 μg) in SCID mice bearing MM1.S: (A) in vivo drug delivery tracking by PET 48 h after administration, (B) rate of tumor growth (whole body photon flux) in response to 89Zr-TiO2-Tf, (C) rate of tumor progression (whole body photon flux) in response to treatment with Zr-TiO2-Tf, (D) rate of tumor progression in response to treatment with 89Zr-oxalate and 89Zr-Tf, (E) representative BLI images showing tumor localization 50 days after implantation.